Clarity Pharmaceuticals Ltd - CU6 share price
About
Clarity Pharmaceuticals Ltd is an Australian clinical-stage radiopharmaceutical company specializing in theranostic (therapy and imaging) products. They utilize their SAR Technology platform to develop innovative solutions for diagnosing, staging, and treating various types of cancers. Their three key products are SARTATE (targeting SSTR2-expressing cancers like neuroblastoma and neuroendocrine tumors), SAR-bisPSMA (targeting PSMA-expressing cancers, particularly prostate cancer), and SAR-Bombesin (used to identify and select patients for subsequent treatment of GRPr-expressing cancers like breast and prostate cancer). Clarity Pharmaceuticals is actively involved in multiple clinical trials, addressing both common and rare/orphan indications of cancer.
Company Profile
Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.
Price Summary
Price Chart
Get Your FREE Report
Discover the Top ASX Stocks to Invest In 2026!
Expert Analysis of Top-Performing ASX Stocks
Market Insights and In-Depth Research
Buy, Sell, And Hold Recommendations
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Reports from Veye
Grab Your FREE Report on Top 5 ASX Stocks to Buy in 2026
Latest Article
